IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress

Go back to IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress
(NASDAQ: IMNN) Delayed: 1.36 -0.02 (1.45%)
Previous Close $1.38    52 Week High
Open $1.40    52 Week Low
Day High $1.42    P/E N/A 
Day Low $1.33    EPS
Volume 62,791